Literature DB >> 1255761

Mutagenicity of metronidazole: presence of several active metabolites in human urine.

W T Speck, A B Stein, H S Rosenkranz.   

Abstract

Mutagenic activity was found in the urine of 10 patients given therapeutic dosages of metronidazole orally or per vagina. Paper chromatographic separation revealed that mutagenicity in the urine was associated with unmodified metronidazole and at least four of its known urinary metabolites. Activity was also recovered in a region of the chromatogram heretofore not assigned to a metronidazole metabolite.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1255761     DOI: 10.1093/jnci/56.2.283

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  7 in total

1.  Mutagens in urine of carbon electrode workers.

Authors:  R Pasquini; S Monarca; G S Sforzolini; R Conti; F Fagioli
Journal:  Int Arch Occup Environ Health       Date:  1982       Impact factor: 3.015

2.  The place of the host-mediated assay.

Authors:  D B McGregor
Journal:  Arch Toxicol       Date:  1980-11       Impact factor: 5.153

3.  Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.

Authors:  D G Lindmark; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

4.  Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazole.

Authors:  Annamaria Buschini; Lisa Ferrarini; Susanna Franzoni; Serena Galati; Mirca Lazzaretti; Francesca Mussi; Cristina Northfleet de Albuquerque; Tânia Maria Araújo Domingues Zucchi; Paola Poli
Journal:  J Parasitol Res       Date:  2009-10-21

5.  Integrated Genotoxicity Testing of three anti-infective drugs using the TGx-DDI transcriptomic biomarker and high-throughput CometChip® assay in TK6 cells.

Authors:  Julie K Buick; Andrea Rowan-Carroll; Rémi Gagné; Andrew Williams; Renxiang Chen; Heng-Hong Li; Albert J Fornace; Christy Chao; Bevin P Engelward; Roland Frötschl; Heidrun Ellinger-Ziegelbauer; Syril D Pettit; Jiri Aubrecht; Carole L Yauk
Journal:  Front Toxicol       Date:  2022-09-23

6.  The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model.

Authors:  A E Davis; F Patterson; R Crouch
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

7.  Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.

Authors:  R C Miller; E J Hall
Journal:  Br J Cancer       Date:  1978-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.